Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
(NASDAQ: CMPS) Delayed: 12.65 +0.02 (0.16%)
Previous Close $12.63    52 Week High $ 
Open $12.21    52 Week Low $ 
Day High $13.00    P/E N/A 
Day Low $12.20    EPS $ 
Volume 2,352,011